The AI Scientist Who Spent 30 Years Solving a Problem Wall Street Said Was Impossible

Before Endotech: The Problem Nobody Wanted to Solve

In 1989, a twenty-one year old student at the Technion Institute of Technology in Israel resolved an NP-complete approximation algorithm that had gone unsolved for over two decades. That student was Anna Becker. It was the moment she understood what AI could actually do — and the beginning of a 30-year obsession with applying it to financial markets.

Her academic journey produced a PhD in Computer Science and AI, a co-authored book on Bayesian networks that has been widely cited in the recent surge of AI development, and research collaborations with some of the largest financial institutions in Europe including AXA and BNP Paribas. She was not a crypto native who discovered trading during the 2017 bull run. She was a quant scientist who arrived at crypto because the volatility created the exact conditions her AI was built to exploit.

Before founding Endotech, Dr. Becker built and sold Strategy Runner — a fintech platform for automated investing adopted by global investment firms operating in foreign exchange and commodities markets. The exit gave her the resources and credibility to pursue the system she had been envisioning since her PhD: an AI with a bird's-eye view of the entire financial market.

The Question That Drove Everything

Throughout her years working with hedge funds and quant teams, Dr. Becker kept asking the same question and kept getting the same response. Every trading algorithm she observed was looking for an edge — a pattern, an indicator, a signal that predicted market movement better than random chance. The problem is that edges expire. The moment a trading signal becomes known in a market, other participants adapt and the edge disappears.

Her question was: why isn't anyone building a system that can see why an edge appears, track when it starts to degrade, and automatically locate the next one? A system with a macro view of all market forces simultaneously rather than a narrow focus on a single signal set.

When she posed this to other quant teams, the response was consistent: "You want a financial god on your side." To see everything simultaneously — all traders, all investors, all events, all forces — you would need to observe the entire financial world at once. It was considered impossible for a small team with finite compute.

Then came GPT. Then came the explosion of large-scale AI infrastructure. And Dr. Becker realized the impossible question now had an answer.

Building the System: 2012 to Now

What Makes Endotech's AI Actually Different

Most products marketed as "AI trading bots" are rule-based algorithms — fixed logic trees that respond to specific technical indicators. These are not AI. They are automation. Endotech's system is structured around what Dr. Becker calls a multi-vector AI approach.

Rather than a single algorithm hunting for a single signal, Endotech deploys over 100 specialized AI modules — each one mastering a specific domain of market knowledge. Some modules analyze microstructure and resistance/support levels. Others process financial news, fundamental data, and market sentiment using deep learning. Others classify market states — identifying whether the market is trending, consolidating, or entering a regime change.

These modules do not operate independently. They feed into a macro-level market states model that contextualizes all individual signals simultaneously and establishes relative priorities. The result is a system that can approximate the "bird's-eye view" that Dr. Becker spent decades trying to build.

The self-improving nature of the system is what separates it from everything that came before. Every 2–3 months, new data sources are ingested, new elements are back-tested, and the model updates. This is why performance has improved over the life of the system rather than degraded — the opposite of what happens with standard trading algorithms.

The 8-Year Track Record in Full

Claims without data are worthless in finance. Here is what 8 years of live operation actually looks like:

Important: Endotech uses fixed capital reporting. Every trade uses the same base capital regardless of prior performance — all profits are treated as if withdrawn. This is intentionally conservative. Compounded returns with Fixed Ratio are significantly higher. The fixed capital figure gives a transparent, conservative picture without mathematical amplification.

The Bit1 Partnership: Why This Moment Matters

For most of Endotech's history, accessing the system required institutional credentials. The minimum investment was $50,000 retail and $125,000 institutional. The partnership with Bit1 Exchange changes that equation completely.

Bit1 is an invitation-only cryptocurrency exchange built around the peer-to-peer economy — you must come through a referral link. This is intentional. The exchange was designed to serve its community rather than extract from it, distributing 60% of all exchange fees back to community members through the IB coding plan.

The Endotech integration is available through copy trading — the AI connects to your Bit1 Futures wallet via API, executes the exact same trades as the master account, and your funds remain in your own wallet at all times. No custody transfer. No offshore accounts. No withdrawal restrictions.

For the complete performance data, custody model, and compensation structure, see the full institutional AI deep review. When you are ready to connect, the step-by-step setup guide is here.

Frequently Asked Questions